Kenneth Ellsworth

Statistics

Publications

Citations

1.4K

H-Index

Active since

1992

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Diabetes Australia

Rosetta Stone (United States)

United States Military Academy

Ionis Pharmaceuticals (United States)

Kenneth Ellsworth is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in life sciences, pharmacology, and enzyme inhibition.

Publications per year

1992–2016

Publications

Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase–1

Guoqiang Jiang, Zhihua Li, Franklin Liu et al. · Journal of Clinical Investigation · 2005 · 256 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase–1

Guoqiang Jiang, Zhihua Li, Franklin Liu et al. · Journal of Clinical Investigation · 2005 · 237 citations

Life Sciences, Biochemistry, Pharmacology +17

Antidiabetic and antisteatotic effects of the selective fatty acid synthase (FAS) inhibitor platensimycin in mouse models of diabetes

Margaret Wu, Sheo B. Singh, Jun Wang et al. · Proceedings of the National Academy of Sciences · 2011 · 146 citations

Life Sciences, Biochemistry, Pharmacology +17

Identification and selective inhibition of an isozyme of steroid 5 alpha-reductase in human scalp.

G. Harris, B. Azzolina, Walter F. Baginsky et al. · Proceedings of the National Academy of Sciences · 1992 · 132 citations

Life Sciences, Biochemistry, Pharmacology +14

Inhibition of rat α-reductases by finasteride: Evidence for isozyme differences in the mechanism of inhibition

B. Azzolina, Kenneth Ellsworth, S Andersson et al. · The Journal of Steroid Biochemistry and Molecular Biology · 1997 · 105 citations

Life Sciences, Biochemistry, Pharmacology +11

1–5 of 23